<DOC>
	<DOCNO>NCT00099346</DOCNO>
	<brief_summary>Study investigational drug patient recurrent non-responsive colorectal cancer advance solid tumor . This early phase trial specific protocol information proprietary publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>MK0457 ( Aurora Kinase Inhibitor ) Study Patients With Advanced Colorectal Cancer Other Advanced Solid Tumors ( 0457-001 )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>In Part I , patient least 18 year age advance solid tumor colorectal cancer eligible first part study . Patient must recover least 3 week previous cancer treatment . In Part II , patient colorectal cancer eligible participate . The patient may receive 3 prior treatment colorectal cancer . Patients must recover least 3 week previous therapy . Patients treatment investigational drug within past 30 day . Patients certain type blood cancer leukemia lymphoma . Patients uncontrolled congestive heart failure ( CHF ) , chest pain , heart attack within past 3 month . Patient pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>